Estimating alcohol marketing exposure

The module on alcohol marketing exposure is four-part and composed of close-ended questions. It goes into:

1) The diverse places where the young have seen or heard any advert or special on alcohol, in the last 12 months. This group of questions was adapted from the AMPHORA survey to the French context and issues:

=> They go through 3 universes:

-    The street and other public spaces including bill boards, public transportations and supermarkets.
-    Information media (radio, magazines and newspapers, Internet). TV was excluded as advertising on TV is banned.
-    Cultural spaces or events (incl. virtual one like movies or video games, sport events and Internet)

Several questions focus on the last alcohol-related advertising that they’ve kept in mind, over the last 30 days. They deal with:

2)    The memorization of the type and brand of the praised beverage of the last remembered advert.
3)    Whether adolescent recognize themselves or not as the direct target of this lastly remembered advert (whether seen or heard).
4)    Whether adolescents liked this advert and whether it succeeded in arousing their desire of drinking.

Access to the module: forthcoming

Drugs in Europe

2016 EMCDDA European Drug Report

- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe

Country situation summaries

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.